Synthesis of bodipy-labeled bacterial polysaccharides and their interaction with human dendritic cells.
Alexander B TuzikovEugenia M RapoportSergey V KhaidukovElena A NokelYuriy A KnirelNicolai V BovinPublished in: Glycoconjugate journal (2021)
In this report, we describe the fluorescent labeling of bacterial polysaccharides (Escherichia coli O86:B7, Escherichia coli O19ab, Pseudomonas aeruginosa O10a10b, and Shigella flexneri 2b) at the "natural" amino group of their phosphoethanolamine moiety. Two protocols for labeling are compared: 1) on a scale of a few mg of the polysaccharide, with a dialysis procedure for purification from excessive reagents; and 2) on a scale of 0.1 mg of the polysaccharide, with a simple precipitation procedure instead of dialysis. The microscale version is sufficient for comfortable cytofluorometric analysis. The resulting probes were found to specifically bind to human dendritic cells in a dose-dependent manner. The used limited set of polysaccharides did not allow us even to get close to understanding which dendritic cell-associated lectins and which cognate polysaccharide epitopes are involved in recognition, but the proposed microscale protocol allows to generate a library of fluorescent probes for further mapping of the polysaccharide specificity of the dendritic cells.
Keyphrases
- dendritic cells
- living cells
- escherichia coli
- water soluble
- endothelial cells
- regulatory t cells
- immune response
- pseudomonas aeruginosa
- fluorescent probe
- chronic kidney disease
- quantum dots
- small molecule
- induced pluripotent stem cells
- pluripotent stem cells
- minimally invasive
- end stage renal disease
- single molecule
- biofilm formation
- fluorescence imaging
- cystic fibrosis
- high resolution
- computed tomography
- weight gain
- mass spectrometry
- high density
- label free
- weight loss
- positron emission tomography
- acinetobacter baumannii